Sergio Oehninger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sergio Oehninger has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Silvina Bocca
The Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, VA, 23507, USA
12 shared publicationsLaurel Stadtmauer
Eastern Virginia Medical School
8 shared publicationsMahmood Morshedi
Eastern Virginia Medical School
6 shared publications- Anahi Franchi
Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk, VA
4 shared publications William E. Gibbons
4 shared publicationsHakan E. Duran
Eastern Virginia Medical School
3 shared publications
Latest Publications
- Open Access
- 1 September 2017
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 6 (S4) , S385-S388
Sperm DNA fragmentation testing: ready for prime time?
Sperm DNA fragmentation testing: ready for prime time?
- 1 September 2017
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 6 (S4) , S385-S388
Open AccessSperm DNA fragmentation testing: ready for prime time?
Sperm DNA fragmentation testing: ready for prime time?
- Open Access
- 31 October 2015
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 13 (1) , 117
Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
This secondary analysis aimed to identify predictors of low (18 oocytes retrieved) in IVF patients undergoing controlled ovarian stimulation with corifollitropin alfa in a gonadotropin-releasing hormone (GnRH) antagonist protocol. Statistical model building for high and low ovarian response was based on the 150 μg corifollitropin alfa treatment group of the Pursue trial in infertile women aged 35–42 years (n = 694). Multivariable logistic regression models were constructed in a stepwise fashion (P <0.05 for entry). 14.1 % of subjects were high ovarian responders and 23.2 % were low ovarian responders. The regression model for high ovarian response included four independent predictors: higher anti-Müllerian hormone (AMH) and antral follicle count (AFC) increased the risk, and higher follicle-stimulating hormone (FSH) levels and advancing age decreased the risk of high ovarian response. The regression model for low ovarian response also included four independent predictors: advancing age increased the risk, and higher AMH, higher AFC and longer menstrual cycle length decreased the risk of low ovarian response. AMH, AFC and age predicted both high and low ovarian responses, FSH predicted high ovarian response, and menstrual cycle length predicted low ovarian response in a corifollitropin alfa/GnRH antagonist protocol. NCT01144416 , Protocol P06029
- 31 October 2015
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 13 (1) , 117
Open AccessPredictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles
This secondary analysis aimed to identify predictors of low (18 oocytes retrieved) in IVF patients undergoing controlled ovarian stimulation with corifollitropin alfa in a gonadotropin-releasing hormone (GnRH) antagonist protocol. Statistical model building for high and low ovarian response was based on the 150 μg corifollitropin alfa treatment group of the Pursue trial in infertile women aged 35–42 years (n = 694). Multivariable logistic regression models were constructed in a stepwise fashion (P <0.05 for entry). 14.1 % of subjects were high ovarian responders and 23.2 % were low ovarian responders. The regression model for high ovarian response included four independent predictors: higher anti-Müllerian hormone (AMH) and antral follicle count (AFC) increased the risk, and higher follicle-stimulating hormone (FSH) levels and advancing age decreased the risk of high ovarian response. The regression model for low ovarian response also included four independent predictors: advancing age increased the risk, and higher AMH, higher AFC and longer menstrual cycle length decreased the risk of low ovarian response. AMH, AFC and age predicted both high and low ovarian responses, FSH predicted high ovarian response, and menstrual cycle length predicted low ovarian response in a corifollitropin alfa/GnRH antagonist protocol. NCT01144416 , Protocol P06029
- 7 January 2015
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 32 (3) , 395-400
Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement
To investigate the impact of late follicular phase serum estradiol (E2) levels on implantation and pregnancy outcomes of cleavage stage cryopreserved/thawed embryos transferred in programmed cycles with exogenous hormonal replacement.
- 7 January 2015
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 32 (3) , 395-400
Impact of serum estradiol levels on the implantation rate of cleavage stage cryopreserved-thawed embryos transferred in programmed cycles with exogenous hormonal replacement
To investigate the impact of late follicular phase serum estradiol (E2) levels on implantation and pregnancy outcomes of cleavage stage cryopreserved/thawed embryos transferred in programmed cycles with exogenous hormonal replacement.
- 1 December 2014
- Published by Elsevier in Fertility and Sterility
- Vol. 102 (6) , 1742-1750.e1
Antimüllerian hormone regulates stem cell factor expression in human granulosa cells
- 1 December 2014
- Published by Elsevier in Fertility and Sterility
- Vol. 102 (6) , 1742-1750.e1
Antimüllerian hormone regulates stem cell factor expression in human granulosa cells
- 21 July 2014
- Published by Springer Nature
- p. 59-68
Sperm Binding to the Zona Pellucida, Hyaluronic Acid Binding Assay, and PICSI
- 21 July 2014
- Published by Springer Nature
- p. 59-68
Sperm Binding to the Zona Pellucida, Hyaluronic Acid Binding Assay, and PICSI
- 22 March 2014
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 31 (6) , 757-765
Characterization of secreted proteins of 2-cell mouse embryos cultured in vitro to the blastocyst stage with and without protein supplementation
- 22 March 2014
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 31 (6) , 757-765
Characterization of secreted proteins of 2-cell mouse embryos cultured in vitro to the blastocyst stage with and without protein supplementation
- Open Access
- 1 January 2014
- Published by Medknow in Asian Journal of Andrology
- Vol. 16 (3) , 500
Lycopene and male infertility: do we know enough?
- 1 January 2014
- Published by Medknow in Asian Journal of Andrology
- Vol. 16 (3) , 500
Open AccessLycopene and male infertility: do we know enough?
- Open Access
- 17 December 2012
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 19 (4) , 250-263
The search for biomarkers of human embryo developmental potential in IVF: a comprehensive proteomic approach
The objective of these studies was to identify differentially expressed peptides/proteins in the culture media of embryos grown during in vitro fertilization (IVF) treatment to establish their value as biomarkers predictive of implantation potential and live birth. Micro-droplets of embryo culture media from IVF patients (conditioned) and control media maintained under identical culture conditions were collected and frozen at −80°C on Days 2–3 of in vitro development prior to analysis. The embryos were transferred on Day 3. The peptides were affinity purified based on their physico-chemical properties and profiled by mass spectrometry for differential expression. The identified proteins were further characterized by western blot and ELISA, and absolute quantification was achieved by multiple reaction monitoring (MRM). We identified up to 14 differentially regulated peptides after capture using paramagnetic beads with different affinities. These differentially expressed peptides were used to generate genetic algorithms (GAs) with a recognition capability of 71–84% for embryo transfer cycles resulting in pregnancy and 75–89% for those with failed implantation. Several peptides were further identified as fragments of Apolipoprotein A-1, which showed consistent and significantly reduced expression in the embryo media samples from embryo transfer cycles resulting in viable pregnancies. Western blot and ELISA, as well as quantitative MRM results, were confirmatory. These results demonstrated that peptide/protein profiles from the culture medium during early human in vitro development can discriminate embryos with highest and lowest implantation competence following uterine transfer. Further prospective studies are needed to establish validated thresholds for clinical application.
- 17 December 2012
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 19 (4) , 250-263
Open AccessThe search for biomarkers of human embryo developmental potential in IVF: a comprehensive proteomic approach
The objective of these studies was to identify differentially expressed peptides/proteins in the culture media of embryos grown during in vitro fertilization (IVF) treatment to establish their value as biomarkers predictive of implantation potential and live birth. Micro-droplets of embryo culture media from IVF patients (conditioned) and control media maintained under identical culture conditions were collected and frozen at −80°C on Days 2–3 of in vitro development prior to analysis. The embryos were transferred on Day 3. The peptides were affinity purified based on their physico-chemical properties and profiled by mass spectrometry for differential expression. The identified proteins were further characterized by western blot and ELISA, and absolute quantification was achieved by multiple reaction monitoring (MRM). We identified up to 14 differentially regulated peptides after capture using paramagnetic beads with different affinities. These differentially expressed peptides were used to generate genetic algorithms (GAs) with a recognition capability of 71–84% for embryo transfer cycles resulting in pregnancy and 75–89% for those with failed implantation. Several peptides were further identified as fragments of Apolipoprotein A-1, which showed consistent and significantly reduced expression in the embryo media samples from embryo transfer cycles resulting in viable pregnancies. Western blot and ELISA, as well as quantitative MRM results, were confirmatory. These results demonstrated that peptide/protein profiles from the culture medium during early human in vitro development can discriminate embryos with highest and lowest implantation competence following uterine transfer. Further prospective studies are needed to establish validated thresholds for clinical application.
- 9 August 2012
- Published by Springer Nature
- Vol. 927, 91-102
The Hemizona Assay for Assessment of Sperm Function
The hemizona assay (HZA) has been developed as a diagnostic test for the tight binding of human spermatozoa to the human zona pellucida to predict fertilization potential. In this homologous bioassay, the two matching hemizona halves are functionally equal surfaces allowing controlled comparison of binding from a fertile control versus a test sample, with reproducible measurements of sperm binding obtained from a single oocyte. Oocytes from different sources (surplus from IVF treatment or recovered from ovarian tissue) are salt-stored and used after microbisection. Extensive clinical data have demonstrated excellent predictive power of the HZA for the outcomes of intrauterine insemination and IVF, and therefore the assay has relevance in the clinical diagnostic setting in infertility.
- 9 August 2012
- Published by Springer Nature
- Vol. 927, 91-102
The Hemizona Assay for Assessment of Sperm Function
The hemizona assay (HZA) has been developed as a diagnostic test for the tight binding of human spermatozoa to the human zona pellucida to predict fertilization potential. In this homologous bioassay, the two matching hemizona halves are functionally equal surfaces allowing controlled comparison of binding from a fertile control versus a test sample, with reproducible measurements of sperm binding obtained from a single oocyte. Oocytes from different sources (surplus from IVF treatment or recovered from ovarian tissue) are salt-stored and used after microbisection. Extensive clinical data have demonstrated excellent predictive power of the HZA for the outcomes of intrauterine insemination and IVF, and therefore the assay has relevance in the clinical diagnostic setting in infertility.